Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously
Status:
Unknown status
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to assess the single dose PK, safety, tolerability and
immunogenicity of abatacept 125mg administered SC in Chinese healthy subjects.